AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 25090173 — intervention group
Group type: EXPERIMENTAL
Intervention: Linkage group (buprenorphine induction, intrahospital dose stabilization, and postdischarge transition to maintenance buprenorphine OAT)
Number of subjects: 145
Study 25090173 — intervention group
Group type: COMPARATOR
Intervention: Detoxification group (five-day buprenorphine detoxification protocol)
Number of subjects: 145
Study 25090173 — intervention group
Group type: EXPERIMENTAL
Intervention: Linkage group
Number of subjects: 145
Study 25090173 — intervention group
Group type: COMPARATOR
Intervention: Detoxification group
Number of subjects: 145
Study 22997755 — intervention group
Group type: EXPERIMENTAL
Intervention: Citoflavin included in the complex program of intensive therapy
Number of subjects: 48
Study 20980215 — intervention group
Group type: EXPERIMENTAL
Intervention: Carvedilol controlled-release (CR)/lisinopril
Number of subjects: 287
Study 20980215 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol/lisinopril
Number of subjects: 287
Study 20980215 — intervention group
Group type: EXPERIMENTAL
Intervention: Lisinopril
Number of subjects: 287
Study 20980215 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 287
Study 18982716 — intervention group
Group type: EXPERIMENTAL
Intervention: General anesthesia based on propofol with fentanyl combination
Number of subjects: 0
Study 18982716 — intervention group
Group type: COMPARATOR
Intervention: Various schemes of general anesthesia
Number of subjects: 0
Study 16097225 — intervention group
Group type: EXPERIMENTAL
Intervention: Chin cup therapy with 600 g of force applied in 13 patients
Number of subjects: 20
Study 16097225 — intervention group
Group type: COMPARATOR
Intervention: Control group (no orthodontic treatment)
Number of subjects: 20
Study 11841593 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin (5 mg p.o.)
Number of subjects: 9
Study 11841593 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study 10445787 — intervention group
Group type: EXPERIMENTAL
Intervention: Colloidal bismuth subcitrate (CBS) 3 x 120 mg + Tetracycline (TET) 3 x 500 mg + Metronidazole (MET) 3 x 250 mg/day
Number of subjects: 131
Study 10445787 — intervention group
Group type: EXPERIMENTAL
Intervention: Colloidal bismuth subcitrate (CBS) 3 x 120 mg + Tetracycline (TET) 3 x 500 mg + Metronidazole (MET) 3 x 125 mg/day
Number of subjects: 131
Study 10445787 — intervention group
Group type: EXPERIMENTAL
Intervention: Colloidal bismuth subcitrate (CBS) 3 x 120 mg + Tetracycline (TET) 3 x 250 mg + Metronidazole (MET) 3 x 125 mg/day
Number of subjects: 131
Study 10445787 — intervention group
Group type: EXPERIMENTAL
Intervention: Increase of MET dose from 375 mg (in groups B and C) to 750 mg/day (in group A)
Number of subjects: 131
Study 7588498 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetate (12 mmol/h)
Number of subjects: 6
Study 7588498 — intervention group
Group type: EXPERIMENTAL
Intervention: Propionate (4 mmol/h)
Number of subjects: 6
Study 7588498 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetate + Propionate (12 mmol/h + 4 mmol/h)
Number of subjects: 6
Study 7588498 — intervention group
Group type: COMPARATOR
Intervention: Isotonic sodium salt solution (saline)
Number of subjects: 6
Study 2179113 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxycycline 100 mg orally twice daily for seven days
Number of subjects: 216
Study 2179113 — intervention group
Group type: COMPARATOR
Intervention: Placebo capsule twice daily for seven days
Number of subjects: 216
Study 6986970 — intervention group
Group type: EXPERIMENTAL
Intervention: Vincristine, Adriamycin and cyclophosphamide alternating with 5‐FU and methotrexate plus BCG or MER‐BCG immunotherapy
Number of subjects: 156
Study 6986970 — intervention group
Group type: COMPARATOR
Intervention: FAC‐BCG (historical control group)
Number of subjects: 156
Study 31618992 — intervention group
Group type: EXPERIMENTAL
Intervention: HAMS (high amylose maize starch) 10 g/day for 2 weeks
Number of subjects: 20
Study 31618992 — intervention group
Group type: EXPERIMENTAL
Intervention: HAMSA (acetylated high amylose maize starch) 10 g/day for 2 weeks
Number of subjects: 20
Study 28387790 — intervention group
Group type: EXPERIMENTAL
Intervention: DAPT with clopidogrel
Number of subjects: 3102
Study 28387790 — intervention group
Group type: COMPARATOR
Intervention: Aspirin alone
Number of subjects: 3102
Study 28387790 — intervention group
Group type: EXPERIMENTAL
Intervention: DAPT with clopidogrel (subgroup of 188 subjects)
Number of subjects: 3102
Study 28387790 — intervention group
Group type: EXPERIMENTAL
Intervention: DAPT with clopidogrel (after matching)
Number of subjects: 3102
Study 28387790 — intervention group
Group type: COMPARATOR
Intervention: Aspirin alone (after matching)
Number of subjects: 3102
Study 25470746 — intervention group
Group type: EXPERIMENTAL
Intervention: Doravirine (6-1,200 mg)
Number of subjects: 82
Study 25470746 — intervention group
Group type: EXPERIMENTAL
Intervention: Doravirine (30-750 mg) once daily for 10 days
Number of subjects: 82
Study 25470746 — intervention group
Group type: EXPERIMENTAL
Intervention: Doravirine (50 mg) with a high-fat meal
Number of subjects: 82
Study 25470746 — intervention group
Group type: EXPERIMENTAL
Intervention: Doravirine (120 mg) coadministered with midazolam
Number of subjects: 82
Study 25470746 — intervention group
Group type: EXPERIMENTAL
Intervention: Doravirine (up to 1,200 mg single doses and up to 750 mg multiple doses)
Number of subjects: 82
Study 25470746 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 82
Study 23402712 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy descriptive norm
Number of subjects: 687
Study 23402712 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy injunctive norm
Number of subjects: 687
Study 23402712 — intervention group
Group type: EXPERIMENTAL
Intervention: Unhealthy descriptive norm
Number of subjects: 687
Study 23402712 — intervention group
Group type: COMPARATOR
Intervention: No-message control condition
Number of subjects: 687
Study 21558406 — intervention group
Group type: EXPERIMENTAL
Intervention: sipuleucel-T
Number of subjects: 176
Study 21558406 — intervention group
Group type: COMPARATOR
Intervention: control
Number of subjects: 176
Study 19532104 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythropoiesis-stimulating agents (ESAs)
Number of subjects: 0
Study 19532104 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron replacement
Number of subjects: 0
Study 19532104 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 18727929 — intervention group
Group type: EXPERIMENTAL
Intervention: Azathioprine (AZA) for 12 months with metronidazole for 3 months
Number of subjects: 81
Study 18727929 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 12 months with metronidazole for 3 months
Number of subjects: 81
Study 15909262 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin at 60 mg/kg per course
Number of subjects: 4626
Study 15909262 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin at 30 mg/kg per course
Number of subjects: 4626
Study 15909262 — intervention group
Group type: EXPERIMENTAL
Intervention: Three-day regimens of azithromycin (500 mg/day) in adults
Number of subjects: 4626
Study 15909262 — intervention group
Group type: EXPERIMENTAL
Intervention: Five-day regimens of azithromycin in adults
Number of subjects: 4626
Study 15909262 — intervention group
Group type: EXPERIMENTAL
Intervention: Three-day regimens vs. five-day regimens
Number of subjects: 4626
Study 15909262 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical cure rates for different azithromycin regimens
Number of subjects: 4626
Study 15909262 — intervention group
Group type: COMPARATOR
Intervention: 10-day comparator antibiotics
Number of subjects: 4626
Study 11888128 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanical compression devices
Number of subjects: 12
Study 11888128 — intervention group
Group type: COMPARATOR
Intervention: Various methods of compression
Number of subjects: 12
Study 10534208 — intervention group
Group type: EXPERIMENTAL
Intervention: Trovafloxacin 200 mg once daily for 5 days
Number of subjects: 970
Study 10534208 — intervention group
Group type: COMPARATOR
Intervention: Doxycycline 100 mg twice daily for 7 days
Number of subjects: 970
Study 7872211 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise (Ex)
Number of subjects: 23
Study 7872211 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-carbohydrate (LC) diet
Number of subjects: 23
Study 2676266 — intervention group
Group type: EXPERIMENTAL
Intervention: Antihypertensive treatment with chlorthalidone and atenolol (or reserpine)
Number of subjects: 4736
Study 2676266 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4736
Study 282689 — intervention group
Group type: EXPERIMENTAL
Intervention: Pack modified by Behlke
Number of subjects: 27
Study 282689 — intervention group
Group type: COMPARATOR
Intervention: Zinc oxide-eugenol pack
Number of subjects: 27
Study 31185327 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-mastectomy intensity modulated proton therapy (IMPT)
Number of subjects: 51
Study 31185327 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypofractionation (median 40.5 Gy/15 fractions)
Number of subjects: 51
Study 31185327 — intervention group
Group type: EXPERIMENTAL
Intervention: Older patient age
Number of subjects: 51
Study 31185327 — intervention group
Group type: COMPARATOR
Intervention: Non-irradiated contralateral breasts
Number of subjects: 51
Study 28492874 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetazolamide + weight management
Number of subjects: 70
Study 28492874 — intervention group
Group type: COMPARATOR
Intervention: Placebo + weight management
Number of subjects: 70
Study 28492874 — intervention group
Group type: COMPARATOR
Intervention: Weight management alone
Number of subjects: 70
Study 25964586 — intervention group
Group type: EXPERIMENTAL
Intervention: RapidArc® (RA)
Number of subjects: 16
Study 25964586 — intervention group
Group type: EXPERIMENTAL
Intervention: Tomotherapy (TT)
Number of subjects: 16
Study 23322466 — intervention group
Group type: EXPERIMENTAL
Intervention: Tocilizumab-MTX 4 mg/kg
Number of subjects: 0
Study 23322466 — intervention group
Group type: EXPERIMENTAL
Intervention: Tocilizumab-MTX 8 mg/kg
Number of subjects: 0
Study 23322466 — intervention group
Group type: COMPARATOR
Intervention: Placebo-MTX
Number of subjects: 0
Study 21176903 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-delivered care
Number of subjects: 701
Study 21176903 — intervention group
Group type: COMPARATOR
Intervention: General practitioner care
Number of subjects: 701
Study 19364000 — intervention group
Group type: EXPERIMENTAL
Intervention: morphine 0.1 mg
Number of subjects: 72
Study 19364000 — intervention group
Group type: EXPERIMENTAL
Intervention: morphine 0.2 mg
Number of subjects: 72
Study 19364000 — intervention group
Group type: COMPARATOR
Intervention: saline (control group)
Number of subjects: 72
Study 18361803 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of traditional chemotherapy drugs with agents that inhibit angiogenesis and EGF signaling pathways
Number of subjects: 0
Study 18361803 — intervention group
Group type: EXPERIMENTAL
Intervention: Agents that inhibit angiogenesis and EGF receptor alone or in combination
Number of subjects: 0
Study 15238021 — intervention group
Group type: EXPERIMENTAL
Intervention: Manipulations of instructions to place importance on either the prospective memory task or the background task (Experiments 1 and 2)
Number of subjects: 0
Study 15238021 — intervention group
Group type: EXPERIMENTAL
Intervention: Manipulations of distinctiveness of prospective memory targets (Experiment 2)
Number of subjects: 0
Study 15238021 — intervention group
Group type: EXPERIMENTAL
Intervention: Manipulation of the difficulty of prospective memory target encoding (Experiments 3 and 4)
Number of subjects: 0
Study 15238021 — intervention group
Group type: EXPERIMENTAL
Intervention: Alternative model evaluation
Number of subjects: 0
Study 11230835 — intervention group
Group type: EXPERIMENTAL
Intervention: Abciximab
Number of subjects: 14644
Study 11230835 — intervention group
Group type: COMPARATOR
Intervention: Eptifibatide or Tirofiban
Number of subjects: 14644
Study 9272805 — intervention group
Group type: EXPERIMENTAL
Intervention: Attentionally demanding task performance in chronic pain patients with high pain intensity and high somatic awareness
Number of subjects: 46
Study 9272805 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic pain patients with high pain intensity and high somatic awareness
Number of subjects: 46
Study 8154032 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 rejection within the first year
Number of subjects: 653
Study 8154032 — intervention group
Group type: EXPERIMENTAL
Intervention: > 1 rejection, the first episode in the first year
Number of subjects: 653
Study 8154032 — intervention group
Group type: EXPERIMENTAL
Intervention: > or = 1 rejection, the first episode after the first year
Number of subjects: 653
Study 8154032 — intervention group
Group type: COMPARATOR
Intervention: no rejection
Number of subjects: 653
Study 3064599 — intervention group
Group type: EXPERIMENTAL
Intervention: Furosemide (50 mg)
Number of subjects: 8
Study 3064599 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril (25 mg)
Number of subjects: 8
Study 3064599 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 31229329 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrogen peroxide skin preparation
Number of subjects: 65
Study 28930903 — intervention group
Group type: EXPERIMENTAL
Intervention: Localized cold therapy
Number of subjects: 0
Study 28930903 — intervention group
Group type: COMPARATOR
Intervention: Control group (no cold therapy)
Number of subjects: 0
Study 25578927 — intervention group
Group type: EXPERIMENTAL
Intervention: 22 g freeze‐dried blueberry powder
Number of subjects: 48
Study 25578927 — intervention group
Group type: COMPARATOR
Intervention: Control powder
Number of subjects: 48
Study 22775199 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin euglycaemic clamp
Number of subjects: 32
Study 22775199 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbohydrate rich 'continental' breakfast
Number of subjects: 32
Study 22775199 — intervention group
Group type: EXPERIMENTAL
Intervention: Calorie reduced 'American' FDA breakfast
Number of subjects: 32
Study 22775199 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 22775199 — intervention group
Group type: EXPERIMENTAL
Intervention: Moxifloxacin without food
Number of subjects: 32
Study 22775199 — intervention group
Group type: EXPERIMENTAL
Intervention: Moxifloxacin with food
Number of subjects: 32
Study 21790306 — intervention group
Group type: EXPERIMENTAL
Intervention: Transfusion with packed red blood cells to achieve high hemoglobin levels
Number of subjects: 1166
Study 21790306 — intervention group
Group type: COMPARATOR
Intervention: No transfusion (Control)
Number of subjects: 1166
Study 18492839 — intervention group
Group type: EXPERIMENTAL
Intervention: Prebiotic-supplemented hypoallergenic formula (8 g/L scGOS/lcFOS)
Number of subjects: 152
Study 18492839 — intervention group
Group type: COMPARATOR
Intervention: Placebo-supplemented hypoallergenic formula (8 g/L maltodextrin)
Number of subjects: 152
Study 17141703 — intervention group
Group type: EXPERIMENTAL
Intervention: Mid-level providers (manual vacuum aspiration)
Number of subjects: 2894
Study 17141703 — intervention group
Group type: COMPARATOR
Intervention: Doctors (manual vacuum aspiration)
Number of subjects: 2894
Study 12696978 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-dose black currant anthocyanins
Number of subjects: 0
Study 12696978 — intervention group
Group type: EXPERIMENTAL
Intervention: Black currant juice
Number of subjects: 0
Study 12696978 — intervention group
Group type: COMPARATOR
Intervention: Anthocyanins
Number of subjects: 0
Study 11020137 — intervention group
Group type: EXPERIMENTAL
Intervention: NuvaRing (etonogestrel 120 microg and ethinylestradiol 15 microg per day)
Number of subjects: 16
Study 11020137 — intervention group
Group type: COMPARATOR
Intervention: DSG/EE COC (desogestrel 150 microg/ethinylestradiol 30 microg)
Number of subjects: 16
Study 9179516 — intervention group
Group type: EXPERIMENTAL
Intervention: Alprazolam (0.5 mg)
Number of subjects: 14
Study 9179516 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 9179516 — intervention group
Group type: EXPERIMENTAL
Intervention: Alprazolam
Number of subjects: 14
Study 1489766 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavior modification
Number of subjects: 40
Study 1489766 — intervention group
Group type: COMPARATOR
Intervention: Traditional education intervention (didactic lectures)
Number of subjects: 40
Study 3516187 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril (50 mg three times a day)
Number of subjects: 18
Study 3516187 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine (20 mg three times a day)
Number of subjects: 18
Study 29330204 — intervention group
Group type: EXPERIMENTAL
Intervention: Pazopanib (600 mg)
Number of subjects: 311
Study 27578377 — intervention group
Group type: EXPERIMENTAL
Intervention: Titanium elastic nail system
Number of subjects: 34
Study 27578377 — intervention group
Group type: COMPARATOR
Intervention: Stainless steel elastic nail system
Number of subjects: 34
Study 24183206 — intervention group
Group type: EXPERIMENTAL
Intervention: Bottle-weaning intervention
Number of subjects: 300
Study 24183206 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 300
Study 24159785 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard therapy plus thermoheliox (group 1)
Number of subjects: 50
Study 24159785 — intervention group
Group type: COMPARATOR
Intervention: Standard method (group 2)
Number of subjects: 50
Study 20697938 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA) at Neixiyan (Ex-LE4), Waixiyan (Ex-LE5), Xuanzhong (GB39), and Taixi (KI3) for 30 min, once a day, for 2 courses with a 5-day interval in between.
Number of subjects: 245
Study 20697938 — intervention group
Group type: COMPARATOR
Intervention: Intra-articular injection of 2 mL hyaluronic acid into the affected joint every 7 days for 5 times in total.
Number of subjects: 245
Study 18787899 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiotropium (18 microg once daily for 7 days)
Number of subjects: 35
Study 18787899 — intervention group
Group type: COMPARATOR
Intervention: Placebo (matched)
Number of subjects: 35
Study 16169256 — intervention group
Group type: EXPERIMENTAL
Intervention: Levetiracetam (LEV) 1000 mg/day to 3000 mg/day as adjunctive therapy
Number of subjects: 178
Study 16169256 — intervention group
Group type: EXPERIMENTAL
Intervention: Levetiracetam (LEV)
Number of subjects: 178
Study 15124554 — intervention group
Group type: EXPERIMENTAL
Intervention: Partial breast irradiation (intraoperative radiotherapy, brachytherapy, or external radiotherapy using 3D conformal radiation therapy)
Number of subjects: 0
Study 15124554 — intervention group
Group type: COMPARATOR
Intervention: Whole breast radiotherapy (50 Gy with an additional boost of 10 to 16 Gy)
Number of subjects: 0
Study 10855594 — intervention group
Group type: EXPERIMENTAL
Intervention: HMO affiliation (Secure Horizons or First Seniority)
Number of subjects: 516
Study 8852474 — intervention group
Group type: EXPERIMENTAL
Intervention: Minocycline
Number of subjects: 60
Study 8852474 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenoxymethylpenicillin
Number of subjects: 60
Study 8852474 — intervention group
Group type: COMPARATOR
Intervention: Control group (not applicable)
Number of subjects: 60
Study 1387528 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery (bypass surgery)
Number of subjects: 263
Study 1387528 — intervention group
Group type: COMPARATOR
Intervention: Percutaneous transluminal angioplasty
Number of subjects: 263
Study 6360774 — intervention group
Group type: EXPERIMENTAL
Intervention: Tripotassium dicitrato bismuthate (TDB)
Number of subjects: 48
Study 6360774 — intervention group
Group type: COMPARATOR
Intervention: Cimetidine
Number of subjects: 48
Study 31060397 — intervention group
Group type: EXPERIMENTAL
Intervention: Cerebral placental ratio (CPR)
Number of subjects: 2852
Study 31060397 — intervention group
Group type: EXPERIMENTAL
Intervention: Umbilical artery pulsatility index (UA PI)
Number of subjects: 2852
Study 31060397 — intervention group
Group type: EXPERIMENTAL
Intervention: Renal artery pulsatility index (RA PI)
Number of subjects: 2852
Study 31060397 — intervention group
Group type: EXPERIMENTAL
Intervention: Systolic diastolic ratio (RA SDR)
Number of subjects: 2852
Study 31060397 — intervention group
Group type: EXPERIMENTAL
Intervention: Peak systolic velocity (RA PSV)
Number of subjects: 2852
Study 30882479 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (intensivists who answered additional questions about patient prognosis)
Number of subjects: 116
Study 30882479 — intervention group
Group type: COMPARATOR
Intervention: Control group (intensivists who did not answer additional questions about patient prognosis)
Number of subjects: 116
Study 30882479 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 116
Study 30882479 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 116
Study 27715348 — intervention group
Group type: EXPERIMENTAL
Intervention: Product B
Number of subjects: 43
Study 27715348 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Control)
Number of subjects: 43
Study 26268496 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined radical operation without breaking lower lip and mandible
Number of subjects: 365
Study 26268496 — intervention group
Group type: COMPARATOR
Intervention: Standard operation (breaking lower lip and mandible)
Number of subjects: 365
Study 24231837 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxybutynin vaginal ring 4 mg daily
Number of subjects: 323
Study 24231837 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxybutynin vaginal ring 6 mg daily
Number of subjects: 323
Study 24231837 — intervention group
Group type: COMPARATOR
Intervention: Placebo vaginal ring
Number of subjects: 323
Study 22541839 — intervention group
Group type: EXPERIMENTAL
Intervention: Cilostazol 100 mg
Number of subjects: 78
Study 19958962 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous allogeneic human mesenchymal stem cells (hMSCs)
Number of subjects: 53
Study 19958962 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 53
Study 18173140 — intervention group
Group type: EXPERIMENTAL
Intervention: Kangyi Zhongyu Decoction (KZD)
Number of subjects: 75
Study 18173140 — intervention group
Group type: COMPARATOR
Intervention: GnRH‐a
Number of subjects: 75
Study 18173140 — intervention group
Group type: EXPERIMENTAL
Intervention: KZD + GnRH‐a
Number of subjects: 75
Study 15293418 — intervention group
Group type: EXPERIMENTAL
Intervention: Single Bond (SB) at 5 s
Number of subjects: 108